Intraday selling pushed 3417.T stock, Ohki Healthcare Holdings Co.,Ltd. (JPX), down 12.14% to JPY 1,281.00 on 07 Feb 2026 on heavy turnover. The share moved between JPY 1,248.00 and JPY 1,314.00 with volume at 160,000.00 shares versus an average of 9,380.00. Traders flagged the sharp drop and elevated relative volume as the primary reason the name appeared among top losers in Japan’s healthcare group.
3417.T stock: Intraday price action and market context
Ohki Healthcare (3417.T) fell 177.00 yen intraday to JPY 1,281.00. Trading saw 160,000.00 shares, a relative volume of 17.06, indicating forced selling or large order flow. Sector peers in Healthcare showed mixed moves, but Ohki’s one-day decline marked it among the top losers on the JPX.
3417.T stock: Fundamentals and valuation snapshot
Ohki Healthcare reports EPS JPY 207.62 and a trailing PE of 6.17, well below the Healthcare sector average PE of 24.12, signaling valuation relative value. Book value per share stands at JPY 2,439.50, and price-to-book is 0.53, which supports a value case. Market capitalization is JPY 17,474,602,656.00, and dividend per share is JPY 26.00.
3417.T stock: Technicals and trading signals
Price sits just above the 200-day average of JPY 1,257.22 and below the 50-day average of JPY 1,427.42, a mixed medium-term technical picture. RSI reads 50.56, ADX 18.10 (no clear trend), and volatility (ATR) is 10.55. Immediate support is the day low JPY 1,248.00 and near resistance is the intraday high JPY 1,314.00.
3417.T stock: Meyka AI grade and forecast
Meyka AI rates 3417.T with a score out of 100: the model score is 72.88, grade B+, suggestion BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of JPY 1,508.93 and a quarterly price of JPY 1,277.77. Compared with the current price JPY 1,281.00, the monthly projection implies an upside of 17.80% and the yearly projection (JPY 1,099.62) implies downside of -14.16%. Forecasts are model-based projections and not guarantees.
3417.T stock: Earnings, growth and cash flow review
Latest financials show revenue and net income growth in FY 2025, with EPS growth of 20.59% year over year. Key metrics include price-to-sales 0.05, EV/EBITDA 5.83, and return on equity 7.63%, suggesting modest profitability and attractive valuation. Operating cash flow and free cash flow per share report as 0.00, which requires monitoring in upcoming reports.
3417.T stock: Risks, catalysts and price targets
Primary risks include weak near-term cash conversion and inventory cycle timing; receivables days are 86.53 and payables days 111.62, creating working capital pressure. Near-term catalysts include FY 2026 earnings due 2026-05-15 and any guidance revisions. Technical price targets: downside support JPY 1,200.00, base target JPY 1,100.00, recovery target JPY 1,450.00, and upside target aligned with Meyka’s monthly model JPY 1,508.93.
Final Thoughts
Ohki Healthcare (3417.T) is an intraday top loser after a steep -12.14% drop to JPY 1,281.00 on 07 Feb 2026 driven by heavy volume and order imbalance. Valuation metrics are compelling, with PE 6.17 and PB 0.53, and the company shows positive EPS growth and a dividend per share of JPY 26.00. However, cash flow line items reported as 0.00 require attention, and receivables days of 86.53 indicate working capital sensitivity. Meyka AI’s forecast model projects a monthly target of JPY 1,508.93, an implied 17.80% upside from current levels, while the yearly model at JPY 1,099.62 shows downside of -14.16%. Traders should weigh the valuation gap against operational cash flow risks, monitor the upcoming 2026-05-15 earnings announcement, and watch volume for follow-through. Meyka AI provides this as an AI-powered market analysis platform insight; forecasts are model-based projections and not guarantees.
FAQs
Why did 3417.T stock fall so sharply intraday?
3417.T stock dropped 12.14% on heavy volume (160,000.00), likely due to large sell orders or profit-taking. Elevated relative volume 17.06 suggests outsized trading rather than normal liquidity-based moves.
Is 3417.T stock undervalued compared with the Healthcare sector?
Yes, valuation looks attractive: Ohki’s PE 6.17 and PB 0.53 sit well below the Healthcare sector average PE 24.12, indicating relative value but also signaling operational or cash flow caution.
What are key near-term catalysts for 3417.T stock?
Key catalysts include the FY 2026 earnings announcement on 2026-05-15, any guidance updates, and shifts in working capital. Positive earnings surprises could rebalance the recent sell-off.
What price targets should investors watch for 3417.T stock?
Watch intraday support JPY 1,248.00, near-term support JPY 1,200.00, and recovery targets JPY 1,450.00 to JPY 1,508.93 per Meyka’s monthly forecast. Use stops given volatility.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)